Close Menu
Home › Aspira Labs to Evaluate GenomeSmart Genetic Test Recommendation Platform

Aspira Labs to Evaluate GenomeSmart Genetic Test Recommendation Platform

Dec 03, 2019
|
staff reporter

NEW YORK — GenomeSmart said on Tuesday that specialty medical technology firm Aspira Labs will evaluate its GenomeBrain digital genetic test recommendation platform under a pilot program.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Jan
28
Featured Webinar

Comprehensive Profiling of Myeloid Malignancies with Reliable Detection of FLT3 and CEBPA

Sponsored by
Sophia Genetics

This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.  

Feb
05
Featured Webinar

Development of a Novel Multiplex Assay: A Partnership Case Study

Sponsored by
LGC

This webinar will provide a behind-the-scenes look at the collaborative development of a novel multiplex assay to speed detection of mosquito-borne illness in the clinical setting.

What's Popular?

In Molecular Diagnostics

  1. Diagnostics Developers Leap Into Action on Novel Coronavirus Tests

    Premium

  2. Adaptive Biotechnologies Prices Public Offering of Stock

  3. Quest Diagnostics Acquires Blueprint Genetics

  4. Biocartis, AstraZeneca Expand Lung Cancer Biomarker Study With Master Collaboration Agreement

  5. Myriad Genetics Seeks Supplemental Approval of HRD Test as CDx for GSK Ovarian Cancer Drug

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.